This inventor holds 1 USPTO granted patent. Top assignees: Riken Corporation, Sysmex Corporation, The Jikei University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 890 
1 out of 1,055 
1 out of 8 Years Active: 2022
Title: Ikuyo Inoue: Innovator in Monoclonal Antibody Research
Introduction
Ikuyo Inoue is a notable inventor based in Wako, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for therapeutic applications, especially in the context of human diseases.
Latest Patents
Ikuyo Inoue holds a patent for an "Antibody against human TGF-β LAP degradate." This patent discloses an isolated monoclonal antibody that recognizes an integrin binding site in the human TGF-β LAP degradate. This innovation could pave the way for new treatments targeting specific pathways in human health.
Career Highlights
Throughout his career, Inoue has worked with prestigious organizations such as Riken Corporation and The Jikei University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Inoue has collaborated with notable colleagues, including Soichi Kojima and Mikako Shirouzu. Their combined expertise has fostered a productive research environment, leading to significant advancements in their field.
Conclusion
Ikuyo Inoue's work in monoclonal antibody research exemplifies the innovative spirit of modern science. His contributions are vital for the ongoing development of targeted therapies in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile